Comment on “A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands”

There is still no convincing evidence for the frequent occurrence of posttranslationally spliced HLA-I peptides. There is still no convincing evidence for the frequent occurrence of posttranslationally spliced HLA-I peptides.

• Publication year

  2019

• Venue

  Science immunology

• Publication date

  2019-08-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1126/sciimmunol.aaw1622PMID 31420320PMCID PMC7039048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of spliced peptides by the proteasome.

  2019cited by this paper
• Global Identification of Post-Translationally Spliced Peptides with Neo-Fusion.

  2018cited by this paper
• Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome*

  2018cited by this paper
• A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands

  2018cited by this paper
• De novo peptide sequencing by deep learning

  2017cited by this paper
• A large fraction of HLA class I ligands are proteasome-generated spliced peptides

  2016cited by this paper
• Application of de Novo Sequencing to Large-Scale Complex Proteomics Data Sets.

  2016cited by this paper
• Comet: An open‐source MS/MS sequence database search tool

  2013cited by this paper
• PEAKS DB: De Novo Sequencing Assisted Database Search for Sensitive and Accurate Peptide Identification*

  2011influential reference
• Use of peptide retention time prediction for protein identification by off-line reversed-phase HPLC-MALDI MS/MS.

  2006cited by this paper

• Protein degradation by human 20S proteasomes elucidates the interplay between peptide hydrolysis and splicing

  2024cites this paper
• The biogenesis of the immunopeptidome.

  2023cites this paper
• The peptide woods are lovely, dark and deep: Hunting for novel cancer antigens.

  2023cites this paper
• Large-Scale Immuno-Peptidome Analysis Reveals Recurrent Post-Translational Splicing of Cancer and Immune-Associated Genes.

  2023cites this paper
• Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example.

  2023cites this paper
• Identification of Alternative Splicing in Proteomes of Human Melanoma Cell Lines without RNA Sequencing Data

  2023cites this paper
• Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases

  2023cites this paper
• Test-Time Training for Deep MS/MS Spectrum Prediction Improves Peptide Identification.

  2023cites this paper
• Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy

  2023cites this paper
• An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool

  2022cites this paper
• Characterization of Proteasome-Generated Spliced Peptides Detected by Mass Spectrometry

  2022cites this paper
• Navigating Critical Challenges Associated with Immunopeptidomics-Based Detection of Proteasomal Spliced Peptide Candidates.

  2022cites this paper
• Neo-Splicetopes in Tumor Therapy: A Lost Case?

  2022cites this paper
• Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors

  2022cites this paper
• Leveraging Immunopeptidomics To Study and Combat Infectious Disease

  2021cites this paper
• Spliced HLA‐bound peptides: a Black Swan event in immunology

  2021cites this paper
• Identification of spliced peptides in pancreatic islets uncovers errors leading to false assignments

  2021cites this paper
• In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo

  2021cites this paper
• Are There Indeed Spliced Peptides in the Immunopeptidome?

  2021cites this paper
• Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics

  2021cites this paper
• Is the Immunopeptidome Getting Darker?: A Commentary on the Discussion around Mishto et al., 2019

  2021cites this paper
• Know thy immune self and non‐self: Proteomics informs on the expanse of self and non‐self, and how and where they arise

  2021cites this paper
• Cloud Computing Based Immunopeptidomics Utilizing Community Curated Variant Libraries Simplifies and Improves Neo-Antigen Discovery in Metastatic Melanoma

  2021cites this paper
• Characterization of HLA-A*02:01 MHC Immunopeptide Antigens Enhanced by Ultraviolet Photodissociation Mass Spectrometry.

  2021cites this paper
• Identification of tumor antigens with immunopeptidomics

  2021cites this paper
• Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer

  2021cites this paper
• RHybridFinder: An R package to process immunopeptidomic data for putative hybrid peptide discovery

  2021cites this paper
• Peptide Presentation to T Cells: Solving the Immunogenic Puzzle: Systems Immunology Profiling of Antigen Presentation for Prediction of CD8+ T Cell Immunogenicity.

  2020cites this paper
• Immunopeptidomics for Dummies: Detailed Experimental Protocols and Rapid, User-Friendly Visualization of MHC I and II Ligand Datasets with MhcVizPipe

  2020cites this paper
• P-VIS: internally-controlled validation of mass spectrometry-based peptide identifications.

  2020cites this paper
• Proteome-Wide Analysis of ADAR-mediated Messenger RNA Editing During Fruit Fly Ontogeny

  2020cites this paper
• A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion

  2020cites this paper
• Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire

  2020cites this paper
• Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer

  2020influential citation
• Response to Comment on “A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands”

  2019cites this paper
• A large peptidome dataset improves HLA class I epitope prediction across most of the human population

  2019cites this paper
• The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases*

  2019cites this paper
• An in silico—in vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

  2019cites this paper
• A subset of HLA-I peptides are not genomically templated: Evidence for cis- and trans-spliced peptide ligands

  2018cites this paper